{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:24:12Z","timestamp":1787239452616,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.thromres.2005.04.011","type":"journal-article","created":{"date-parts":[[2005,5,24]],"date-time":"2005-05-24T07:35:41Z","timestamp":1116920141000},"page":"507-515","source":"Crossref","is-referenced-by-count":54,"title":["Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and\/or coumarin explain the rapid shift in clinical practice during the 1990s"],"prefix":"10.1016","volume":"117","author":[{"given":"Norbert","family":"Lubenow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore E.","family":"Warkentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Greinacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Wessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debi-Ann","family":"Sloane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica L.","family":"Krahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry N.","family":"Magnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2005.04.011_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0049-3848(03)00336-0","article-title":"Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban","volume":"110","author":"Warkentin","year":"2003","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2005.04.011_bib2","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin","volume":"332","author":"Warkentin","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2005.04.011_bib3","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/archinte.163.20.2518","article-title":"An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients","volume":"163","author":"Warkentin","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.thromres.2005.04.011_bib4","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0140-6736(82)90106-4","article-title":"Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis in platelet aggregation","volume":"2","author":"Chong","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2005.04.011_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1182\/blood.V67.1.27.27","article-title":"A diagnostic test for heparin-induced thrombocytopenia","volume":"67","author":"Sheridan","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2005.04.011_bib6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-2004-831039","article-title":"An overview of the heparin-induced thrombocytopenia syndrome","volume":"30","author":"Warkentin","year":"2004","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2005.04.011_bib7","first-page":"691","article-title":"Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia","volume":"843","author":"Warkentin","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2005.04.011_bib8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/09537109975960","article-title":"Generation of platelet-derived microparticles and procoagulant activity by heparin-induced thrombocytopenia IgG\/serum and other IgG platelet agonists: a comparison with standard platelet agonists","volume":"10","author":"Warkentin","year":"1999","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2005.04.011_bib9","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood.V96.1.188","article-title":"Morphological analysis of microparticle generation in heparin-induced thrombocytopenia","volume":"96","author":"Hughes","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2005.04.011_bib10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM198703053161004","article-title":"Immune endothelial-cell injury in heparin-associated thrombocytopenia","volume":"316","author":"Cines","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2005.04.011_bib11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1172\/JCI116987","article-title":"Antibodies from patients with heparin-induced thrombocytopenia\/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells","volume":"93","author":"Visentin","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.thromres.2005.04.011_bib12","first-page":"247","article-title":"Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen","volume":"71","author":"Greinacher","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2005.04.011_bib13","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1182\/blood.V97.10.3300","article-title":"Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia","volume":"97","author":"Populard","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2005.04.011_bib14","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1182\/blood.V98.4.1252","article-title":"Antibodies from patients with heparin-induced thrombocytopenia stimulate monocytic cells to express tissue factor and secrete interleukin-8","volume":"98","author":"Arepally","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2005.04.011_bib15","doi-asserted-by":"crossref","first-page":"804","DOI":"10.7326\/0003-4819-127-9-199711010-00005","article-title":"The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia","volume":"127","author":"Warkentin","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.thromres.2005.04.011_bib16","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1182\/blood.V96.3.846","article-title":"Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range","volume":"96","author":"Greinacher","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2005.04.011_bib17","doi-asserted-by":"crossref","first-page":"489S","DOI":"10.1378\/chest.114.5_Supplement.489S","article-title":"Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety","volume":"114","author":"Hirsh","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2005.04.011_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0037-1614206","article-title":"Heparin-induced thrombocytopenia: towards consensus","volume":"79","author":"Warkentin","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2005.04.011_bib19","doi-asserted-by":"crossref","first-page":"311S","DOI":"10.1378\/chest.126.3_suppl.311S","article-title":"Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Warkentin","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2005.04.011_bib20","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1182\/blood.V78.9.2194.2194","article-title":"Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia","volume":"78","author":"Demers","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2005.04.011_bib21","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1055\/s-0038-1649626","article-title":"Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with Orgaran (Org 10172)","volume":"70","author":"Magnani","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2005.04.011_bib22","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1055\/s-0038-1648434","article-title":"Parenteral anticoagulation with the heparinoid Lomoparan (Org 10172) in patients with heparin induced thrombocytopenia and thrombosis","volume":"67","author":"Ortel","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2005.04.011_bib23","first-page":"74","article-title":"Orgaran (danaparoid sodium) use in the syndrome of heparin-induced thrombocytopenia","volume":"8","author":"Magnani","year":"1997","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2005.04.011_bib24","first-page":"371","article-title":"Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia","volume":"120","author":"Warkentin","year":"1992","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.thromres.2005.04.011_bib25","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1055\/s-0038-1646493","article-title":"A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia","volume":"66","author":"Greinacher","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2005.04.011_bib26","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1055\/s-0037-1614536","article-title":"First workshop for detection of heparin-induced antibodies: validation of the heparin-induced platelet-activation test (HIPA) in comparison with a PF4\/heparin ELISA","volume":"81","author":"Eichler","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2005.04.011_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/01.CIR.99.1.73","article-title":"Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with the immunologic type of heparin-induced thrombocytopenia: A prospective study","volume":"99","author":"Greinacher","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2005.04.011_bib28","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/01.CIR.100.6.587","article-title":"Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia","volume":"100","author":"Greinacher","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2005.04.011_bib29","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1161\/01.CIR.103.14.1838","article-title":"Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia","volume":"103","author":"Lewis","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2005.04.011_bib30","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/archinte.163.15.1849","article-title":"Argatroban-915 Investigators. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia","volume":"163","author":"Lewis","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.thromres.2005.04.011_bib31","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1055\/s-0037-1616046","article-title":"Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopaenia with thrombosis: a clinical outcome study","volume":"86","author":"Chong","year":"2001","journal-title":"Thromb Haemost"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384805001696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384805001696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T07:36:03Z","timestamp":1586244963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384805001696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0049384805001696"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2005.04.011","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}